The aim of this review is to highlight the role of invasive functional evaluation in patients in whom coronary artery bypass graft (CABG) is indicated, and to examine the clinical evidence available in favour of fractional flow reserve (FFR) adoption in these patients, outline appropriate use, as well as point out potential pitfalls. FFR after CABG will also be reviewed, highlighting its correct interpretation and adoption when applied to both native coronary arteries and bypass grafts. Practice European guidelines support the use of FFR to complement coronary angiography with the highest degree of recommendation (Class IA) for the assessment of coronary stenosis before undertaking myocardial revascularization when previous non-invasive functional evaluation is unavailable or not conclusive. As a result, FFR has been adopted in routine clinical practice to guide clinicians decision as to whether or not perform a revascularization. Of note, due to the increasing confidence of the interventional cardiologists, FFR guidance is also being implemented to indicate or guide CABG. This is in anticipation of supportive clear-cut evidence, since recommendations for FFR adoption were based on randomized clinical trials investigating percutaneous coronary intervention (PCI) strategies in which patients with typical indications for CABG were excluded (e.g. left main disease, valvular disease, and coronary anatomy unsuitable for PCI). Based on the critical appraisal of the literature, FFR can play an important role in risk stratification and determining management strategy of patients either before or after CABG.
Introduction
Coronary angiography (CAG) has represented the benchmark diagnostic examination for the assessment of coronary atherosclerotic disease. 1 For the majority of interventional cardiologists, CAG is the only invasive test deemed necessary for clinical decision-making, despite its weak ability to predict the functional impact of atheroma on the subtended myocardium. 2, 3 To overcome this limitation, different adjunctive diagnostic tools have been introduced. Fractional flow reserve (FFR), in particular, has proved effective to complement CAG by disclosing whether the coronary stenosis is responsible for reversible myocardial ischaemia which is ultimately the cause for patient's complaints. 4, 5 A Class IA recommendation has been granted to the use of FFR in the assessment of coronary stenosis before myocardial revascularization when previous non-invasive functional evaluation is unavailable or not conclusive. 6 Over time, FFR has been increasingly adopted in routine clinical practice also to indicate or guide surgical bypass revascularization (CABG), anticipating supportive clear-cut evidence. 7 In fact, recommendations for FFR adoption are based on randomized clinical trials investigating percutaneous coronary intervention (PCI) strategies, where patients with typical indications for CABG were excluded. 8, 9 This review focuses on the role of FFR to guide surgical revascularization and to assess the functional significance of diseased bypass grafts.
Fractional flow reserve
Fractional flow reserve is defined as the maximal myocardial blood flow in a stenotic artery expressed in per cent of the normal maximal flow, i.e. in the hypothetical case the epicardial artery would be normal. 4, 5 FFR is a ratio of two flows that can be calculated as the ratio of two pressures, namely distal coronary pressure and aortic pressure. FFR is commonly assessed during CAG by means of a 0.014 00 pressure guidewire (or more recently also by a rapid exchange pressure sensor-tipped micro-catheter) that is inserted under fluoroscopic guidance into the stenotic coronary artery. Once the pressure wire has been positioned distal into the stenosis, a vasodilator is administrated (commonly adenosine) either intracoronary (i.c.) or intravenously (i.v.) in order to achieve maximal myocardial blood flow. FFR has been validated against multiple non-invasive functional tests that have identified: (i) a value of 0.75 or lower to detect coronary stenosis associated with 100% certainty of reversible myocardial ischaemia and (ii) a value of 0.80 or higher to detect coronary stenosis not associated with myocardial ischaemia with more than 95% certainty. 4 Subsequently, a threshold value of 0.80 has been validated in outcome studies demonstrating clear clinical advantages for the patients when revascularization strategies were guided by FFR assessment. 8, [10] [11] [12] In the FFR vs. angiography for guiding PCI (FAME) trial, an FFR-guided PCI (i.e. deferring PCI with FFR >0.80, while performing PCI with FFR 0.80) was compared with an angiography-guided PCI (i.e. performing or deferring PCI on the basis of the angiographic significance of the coronary stenoses) strategy in patients with multivessel disease (MVD). The FAME trial was the first randomized trial demonstrating a clinical superiority of an FFR-guided revascularization strategy in terms of major adverse cardiovascular events (MACE) at 1 year (primary endpoint) and in terms of death or myocardial infarction at 2 years, combined with a significant cost savings (e.g. less drug eluting stents implanted). 8, 10 In the FAME 2 trial, stable patients with known coronary artery disease and at least one stenosis with FFR 0.80 were randomized either to a conservative optimal medical treatment or to an FFR-guided PCI combined with optimal medical treatment. The FAME 2 trial demonstrated a superior clinical benefit of the FFR-guided revascularization over the conservative treatment in these patients, with an interesting interaction with lower rate of death or myocardial infarction.
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Specificities of functional evaluation in the setting of coronary artery bypass graft
Non-invasive functional assessment of patients with typical indications for CABG is particularly difficult and sometimes inconclusive. 13, 14 These patients often present with left main coronary stenosis (LM) or MVD, where non-invasive functional tests have shown to have lower diagnostic accuracy (e.g. spatial resolution), 15, 16 or with concomitant valve disease in which case they may be unable to exercise or undergo pharmacologic stress tests ( Table 1) . In these patients, inadequacy of CAG in defining the stenoses responsible for reversible myocardial ischaemia has been confirmed, with less than half of the patients classified with angiographic MVD actually having functionally significant MVD. 17 This suggests that bypass graft anastomoses are often implanted on coronary arteries with no functionally significant lesions. The threshold to perform a graft anastomosis has been rather low, based on the belief that it is better to revascularize even mildly stenotic vessels (implanting the so-called 'stand-by graft') rather than leaving something behind that might be significant despite mild angiographic appearance. Near-infrared fluorescence angiography studies showed that up to one-fourth of the grafted vascular myocardial arteries had no regional myocardial perfusion changes after the operation, suggesting limited or no perfusion benefit from the additional vascular conduits. 18 Bypass grafting where not strictly needed, for example on a coronary artery with non-significant stenoses, might not just be futile but also potentially harmful for both the native vessel and the bypass graft. Beyond the potential iatrogenic events from technical failure of the operator (e.g. suboptimal anastomosis with consequent luminal stenosis), implanting a bypass graft on a vessel not significantly diseased might result over time in atherosclerotic progression in the subtended native coronary artery. 19 Although this may occur in all kinds of grafted coronary arteries, the risk of accelerated atherosclerosis seems to be higher in vessels grafted with venous rather than arterial bypasses. 20 The clinical impact of this accelerated atherosclerosis has, however, been questioned in a recent large retrospective registry showing no significant interaction with patients' survival. 21 Regarding arterial conduits, intra-coronary Doppler studies have demonstrated important flow reduction in internal thoracic arteries (ITAs) used to bypass mildly or moderately stenotic coronary arteries. 22 In analogy to native coronary arteries, this flow modulation can be attributed to the auto-regulatory ability of the ITA to change its size and blow flow according to the oxygen demand of the myocardial region perfused. There is in fact a strong correlation between ITA diameter and stenosis severity of the recipient coronary artery. 23 The competitive flow from the native coronary artery increases proportionally with decreasing stenosis severity, eventually leading to a fall in the flow demand from the ITA and over time to the possible atrophy or occlusion of the arterial graft ( Figure 1 ). This mechanism explains the very high attrition rate in grafts (between 50% and 80%) observed when the ITA is anastomosed on coronaries with mild stenosis severity (e.g. <50%). [23] [24] [25] The diameter of the recipient coronary artery and the extent of the revascularized myocardial territory play an even more important role in the patency rate of saphenous venous grafts (SVGs). 26 This is suggested by the higher 10-year patency rate of SVGs implanted on the left anterior descending artery, as compared with those implanted on the circumflex or on the right coronary artery. 26 After the internal thoracic artery, the radial artery (RA) is used by preference to other arterial conduits, because of its calibre, length, and technical ease of isolation and harvesting. However, conflicting results on short-and long-term patency rate of RA grafts have been reported during the last 15 years. 27, 28 The exact mechanism of the RA graft failure is not completely known, though it might be partly attributed to the high propensity of this arterial conduit for vasospasm. This increased vasoreactivity, however, of the denervated RA diminishes with time. Importantly, the patency of the RA grafts is highly dependent from the stenosis severity in the native coronary artery. In fact, an optimal patency rate of RA grafts has been reported up to 20 years especially with tight native coronary stenoses (>90% diameter stenosis). 29 The patency rate of the RA significantly decreases [both in terms of anatomic or functional occlusion (i.e. string sign)], when this is anastomosed on coronary arteries with less severely diseased. 30 Therefore, especially in case RA grafts are used a careful assessment of stenosis severity of the native coronary artery, for example with adjunctive FFR assessment, might be particularly important in warranting a favourable outcome of this arterial conduit. When correctly implanted, the long-term clinical and angiographic outcomes of the RA grafts are at least similar to those of the right internal thoracic artery (RITA), and certainly superior to the SVG.
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Patients with isolated left main coronary stenosis
Significant LM disease is defined by a diameter stenosis 50% and it occurs in 4-7% of patients undergoing CAG. 33 Yet, short segment length and ostial locations make the estimation of the stenosis severity difficult in LM: (i) the catheter may overlap and mask the ostium or the origin of the left anterior descending artery (LAD) and/or the left circumflex (LCx); (ii) spill-over of contrast medium with the consequent incomplete mixing with blood in the proximal part of the LM may render the evaluation of an ostial lesion difficult; (iii) interobserver variability of the angiographic stenosis evaluation is very large, and usually tools like quantitative CAG do not perform better than visual assessment in detecting haemodynamically significant stenosis. 34 Of note, the risk of underestimating significant disease in the LM is not negligible, with an FFR <0.80 found in 23% of patients with <50% diameter stenosis. 35 Had the decision in such cases been taken only on angiographic evaluation, revascularization would have been denied in up to one-fourth of the patients. On the contrary, an LM stenosis with preserved FFR may be safely treated with optimal medical therapy, as deferred revascularization based on FFR above 0.80 is associated with favourable clinical outcome up to 5 years. 35 Potential pitfalls and limitations During the assessment of LM lesions, particular attention should be given to the choice of the guiding catheter (GC). In fact, even with an apparently healthy LM ostium, the mere presence of the GC might induce functional stenosis, with consequent pressure damping that proportionally increases with increasing French size of the GC. The practical consequence is the limitation of the hyperaemic flow response to adenosine, leading to an overestimation of the true FFR value. 36 GCs with side-holes are not recommended in FFR assessment. In fact, a normal-looking pressure tracing obtained through a GC with side-holes can mask a possible flow impediment. 36 The pressure sensor (located 3 cm from the radiopaque tip of the wire) should be placed just outside the tip of the GC to allow the initial calibration manoeuvre (equalization) before introducing the pressure wire into the coronary artery in question. In the assessment of equivocal LM stenosis, performing equalization with the GC disengaged is not strictly necessary, unless major pressure damping is observed (Figure 2) .
After the placement of the pressure guidewire sensor distal into the coronary artery, the hyperaemic state is best induced with intravenous infusion of adenosine (at a dose of 140 lg/kg/min). In fact, the stable steady-state hyperaemic response enables the operator to safely disengage the GC in order to unmask possible limitations to the hyperaemic response induced by the GC dwelling in the coronary ostium. In addition, steady-state hyperaemia allows performance of the pullback manoeuvre that is critical to assess the relative contribution of possible downstream atherosclerotic disease to the overall functional impact derived from the LM stenosis. 36 The administration of i.c. adenosine in bolus (at a dose of 200 lg) is possible especially in the case of LM stenosis located in the shaft or at the bifurcation. A brisk injection of the adenosine bolus, followed by a quick disengagement of the GC (for example, by gently pushing the pressure guidewire sensor forward), is recommended in order to free the coronary ostium. Use of i.c. adenosine is less convenient than i.v. infusion, and to be recommended in this setting only in experienced hands. 36, 37 Patients with multivessel disease with or without associated LM stenosis
When low-to-intermediate risk patients with MVD are treated with functionally (FFR)-guided percutaneous revascularization, an improved clinical outcome has been observed as compared with an angiography-guided strategy. 10 This beneficial clinical impact was preserved up to 5 years, and it was obtained mainly following functional reclassification of the anatomic severity of atherosclerotic disease. 38 In a subanalysis of the FAME trial, Nam et al. 39 The ongoing FAME 3 trial randomizes patients with MVD either to FFR-guided percutaneous revascularization or to a state-of-the-art surgical revascularization strategy. 42 The primary endpoint of FAME 3 is non-inferiority for MACE at 1 year between the two treatment strategies. The results of the FAME 3 trial will be particularly important to confirm whether FFR could be the 'gate keeper' between percutaneous or surgical revascularization in selected patients with MVD (i.e. in those patients with equipoise between PCI and CABG, but not in patients excluded from randomization, for example patients with left main or concomitant valve disease).
Potential pitfalls and limitations
In patients with MVD, the presence of collateralized vessels is not infrequent. The reliability of FFR in stenotic donor vessels has been challenged: i.e. by accounting for a larger myocardial territory, the functional assessment of stenosis severity in the donor vessel might be over-estimated compared with the true functional significance of the same vessel not providing collaterals to a remote territory. In most of the cases, chronic total occlusions are located either on the right (up to 50%) or on the LCx coronary artery (up to 16%). 43 These vessels generally supply small myocardial territories; therefore, the change in FFR values in the donor vessels that can be expected after having re-canalized the occluded one is generally limited. 44 Fractional flow reserve assessment of MVD patients is also challenged by the presence of an LM stenosis ( Figure 3) . The functional severity of an LM stenosis is influenced by the presence of a downstream lesion in one of the two daughter vessels. Theoretically, the true functional severity of the LM lesion should be that obtained after having relieved the resistance opposed by the distal lesion. By stenting the downstream stenosis, FFR of the LM lesion is expected to decrease ( Figure 3C) . On the contrary, the implantation of a bypass graft beyond the downstream stenosis would supply the subtended myocardial territory; therefore, relieving the distal vascular resistance and resulting in an FFR value unchanged or slightly increased ( Figure 3D) .
Recent studies both in vitro and in vivo have addressed this issue by assessing the reliability of FFR measurements in the non-diseased daughter artery to predict the true functional severity of the LM stenosis. 45 In most cases, one can reliably measure an LM stenosis by placing the pressure wire in the contralateral non-stenotic daughter vessel: an FFR value >0.85 would never turn out to be an FFR value below 0.80 when the distal stenosis is not critical. In contrast, the presence of a critical downstream stenosis (i.e. with an FFR value <0.65 when the pressure wire is placed in the stenotic daughter vessel) might significantly impact the true FFR value of the LM lesion. In these situations, it is advisable to perform i.c. imaging assessment, which has demonstrated an excellent correlation with FFR in the LM (Figure 4) . To advance the pressure wire within the left coronary artery, the GC was engaged, with a massive pressure damping. Here, a misalignment of the two pressures was noticed (see detailed enlargement) that was addressed by repeating the equalization that leads to perfect overlapping of the two pressures again. (C) To minimize the flow disturbances at the ostium of the left main, the GC was disengaged, but this time inverse drift was noticed, with the sensor pressure higher than the GC pressure. 
Patients with combined coronary artery and valve disease
In patients with severe aortic stenosis (AS), the prevalence of significant CAD ranges from 25% to 50%. 46 When both conditions are present and symptoms occur, current guidelines recommend surgical treatment with combined aortic valve replacement (AVR) and CABG. 47 Nevertheless, comorbidities that might often be present, especially in elderly patients, could potentially prevent the adoption of appropriate treatment. 48 In the meantime, the growing adoption of transcatheter aortic valve implantation (TAVI) has further extended percutaneous invasive treatment of AS from elderly highrisk patients not considered suitable candidates for surgical AVR to intermediate risk patients. 49 Severity of CAD appears to be associated with impaired clinical outcomes at 1 year after TAVI. 50 Whether revascularization strategies in this setting might also target functionally significant stenoses is still under active investigation ( Table 2) . In a recent retrospective registry from Di Gioia et al.
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, FFR guidance significantly impacted the management of selected patients with moderate or severe AS and coronary artery disease by resulting in deferral of AVR, with more patients treated with PCI. In patients treated with CABG, FFR-guidance resulted into fewer venous grafts and anastomoses without increasing adverse event rates up to 5 years. To date, the only ongoing randomized controlled trial designed to assess the impact of FFR-guided revascularization in patients with valvular disease is the SAVE-IT trial ( Table 2) . 52 The purpose of this study is to determine in patients undergoing elective valve heart surgery, whether revascularization of concomitant CAD guided by FFR is superior to a standard angiographyguided revascularization approach with regard to major efficacy and safety outcomes.
Potential pitfalls and limitations
In patients with valvular disease, maximal hyperaemia is best obtained by the administration of an i.c. adenosine bolus to prevent a potential severe hypotensive response, even though some reports did not show major untoward effects when administrating adenosine i.v. 53 Due to the presence of associated left ventricular hypertrophy, the hyperaemic response might be suboptimal therefore resulting into an underestimation of the functional severity of the coronary stenosis (i.e. higher FFR values). The clinical impact of this potential underestimation seems to be limited in the available retrospective study, 51 and it deserves further prospective investigations.
Use of fractional flow reserve in graft conduits
Percutaneous coronary intervention of bypass grafts is associated with higher rates of MACE as compared with PCI of native vessels, mainly because of the higher rate of periprocedural myocardial infarction and repeat revascularization. 54 Stenoses in bypass grafts are At the multivariate analysis, MACE and cerebrovascular events rate were lower in the FFR-guided group as compared with the angiography-guided group, with a significant overall reduction in procedural costs. This clinical benefit was more pronounced in the arterial grafts, whereas it was limited in SVG's.
Potential pitfalls and limitations
Two important factors should be considered when performing FFR assessment of post-CABG patients: (i) the potential for competing flow and pressure from both the native and conduit vessels; and (ii) the presence of collaterals from long-standing native coronary occlusion. Other issues pertinent to type of graft assessed should be considered. Saphenous vein grafts are larger in calibre and have different vessel wall constituents compared with native coronary arteries. The SVG anastomosis can itself cause a pressure drop; diffuse disease in the vascular bed distal to the anastomosis, as occurs with diabetics, could cause abnormal results of stress myocardial perfusion imaging despite a normal FFR across the lesion in question. In addition, resistance to antegrade flow is different among arterial and venous grafts.
In particular, the resistance of the left internal thoracic artery (LITA) appears significantly higher than that of the RITA or of the SVG, as reflected by lower FFR and higher pressure drop through the LITA 57 Several factors could contribute to this finding. First, the territory of the LAD on which the LITA is preferentially implanted is likely to require a larger blood flow supply than that of the other territories for which SVGs or RITAs are more often used. Blood flow (F) directly relates with pressure gradient (DP) across the coronary circulation and inversely with both epicardial (R epi ) and microvascular (R micro ) resistances (F ¼ DP/ R epi þ R micro ). The LAD supplies the largest myocardial area with the wider microvasculature network. During maximal hyperaemia, microvascular dilation in this territory is remarkable, therefore resulting not only into massive increase in myocardial blood flow but also into a more pronounced pressure gradient increase. Second, differences in the three-dimensional configuration of various types of grafts could affect the transmission of the pressure wave: curvatures of the proximal LITA may result in some damping of the pressure waveform that could explain a resistance to phasic pulsatile flow superior to that of the right ITA whose configuration is more rectilinear. Third, differences in length and lumen diameter of graft conduits are parameters directly affecting their resistance to flow. Therefore, in the assessment of lesions located on the LITA to the LAD, it is advisable to perform FFR measurement under continuous infusion of adenosine, to allow a pullback manoeuvre in order to unmask focal hyperaemic gradients suitable for PCI ( Figure 5 ). Measurement of FFR across bypass graft stenoses should be different, depending on whether the native coronary artery is occluded or open (competitive flow). In case the native vessel is occluded, procedure and interpretation of the results are the same as during standard FFR measurement of native coronary artery lesions ( Figure 6 ). In case the native vessel is still open, the sensor of the pressure wire should be placed distally to the distal anastomosis (either via the graft or via the native artery), to account for the cumulative effect of the overall atherosclerotic burden on the perfusion of the downstream myocardial area. In the latter case, if FFR is below 0.80, it means that the native artery and the bypass graft together are not able to provide sufficient antegrade flow to the subtended myocardium. Selection of the vascular conduit to be treated follows technical consideration and operator's preference (e.g. stenting the native vessel in case of an old, degenerated venous graft). In case of jump grafts, we can speculate that the invasive functional evaluation with FFR is still viable, though it should additionally take into account all the pitfalls applying to FFR assessment of serial stenoses and bifurcation lesions. [58] [59] [60] Usefulness of fractional flow reserve in coronary artery bypass graft candidates
The 1-year patency rate of bypass grafts has been prospectively correlated with the functional severity of the native coronary stenosis. 61 FFR was assessed in all the stenotic vessels in 164 patients indicated for surgical revascularization. The FFR values were undisclosed and CABG was performed following the surgeons' best evaluation of the anatomic stenosis severity based on CAG. At 1 year, the occlusion rate of the bypass grafts implanted on functionally non-significant stenoses (with preserved FFR values) was twice as high compared with that of bypass grafts implanted on functionally significant stenosis. Of interest, the higher occlusion rate was equally observed in both arterial and venous grafts. However, the clinical impact of the higher occlusion rate was mitigated by the fact that the occluded bypass grafts were implanted on vessels without significant stenoses and flow sufficient for supplying the myocardial region of reference. This is suggested by the lack of difference in angina class and repeat revascularization between patients with and without occluded bypass grafts.
A surgical revascularization strategy guided by FFR measurement was compared retrospectively with a traditional strategy guided by CAG only. In 627 patients, FFR-guidance was associated with a significant downgrading of the rate of MVD. 7 This reclassification of patients led to a simplification of the surgical protocol as suggested by the lower number of anastomosis and lower rate of on-pump surgery observed in the FFR-guided CABG group of patients. Despite incomplete anatomical revascularization of these latter patients, at 3 years there was no difference in terms of adverse cardiac events and an even lower rate of angina Canadian Class Society Class II-IV as compared with patients treated with a traditional strategy, suggesting the safety of performing functionally complete revascularization in these patients. In addition, an exploratory analysis showed that graft patency rate was higher when surgical revascularization was guided by FFR compared with angiography, confirming and extending up to 3 years the previous findings. 61 The GRAFFITI trial is currently recruiting patients with MVD either to an angiography-guided or to an FFR-guided surgical revascularization (Table 2) . 62 The primary endpoint of the GRAFFITI trial is the graft patency rate at 1 year between the two strategies. If the initial promising results in favour of the FFR-guided CABG observed in the singlecentre registries are confirmed, there may be interesting implications for revascularization strategies to be considered in patients who otherwise are candidates for traditional CABG. For example, an FFR-guided approach might encourage hybrid revascularization strategies especially in patients with borderline non-functionally significant stenoses of the LCX or RCA, or in patients with concomitant aortic valve stenosis. Anatomically complete revascularization would mean the implantation of one or two arterial conduits, with one or more venous bypasses in patients with MVD, or AVR with additional aorto-coronary bypass in patients with concomitant valve disease. Today, by applying a functionally guided CABG strategy, we could more easily offer full (functional) arterial revascularization to these patients by implanting the best available arterial vascular conduits, i.e. the ITA to the LAD, Figure 5 Example of fractional flow reserve measurement of a distal stenosis located in the shaft of the left internal thoracic artery implanted on the mid-LAD. Note that the proximal LAD is occluded; therefore, the left internal thoracic artery is fully perfusing the LAD territory. Fractional flow reserve is performed with intravenously adenosine infusion. At pullback of the pressure sensor, a step-up gradient was noticed corresponding to the distal left internal thoracic artery stenosis, followed by some residual gradient over the remaining left internal thoracic artery (A and D). Consistently, a stent implantation was performed (B), with good angiographic result (C).
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Conclusions
Fractional flow reserve can play an important role in risk stratification and determining management strategy of patients either before or after CABG. The available data are mostly observational and seem to support the reliability and prognostic role of FFR in these patients. While waiting for the results of ongoing randomized clinical trials, FFR can be used to guide revascularization strategies, taking into account the divergent visions of the cardiac surgeons who aim for once-in-a-lifetime treatment of the patients, and that of the interventional cardiologists who have the option of deferring percutaneous revascularization to a later stage. 
